Tag: MedAlliance

Cordis

Cordis announces acquisition of MedAlliance

Cordis today announced its acquisition, subject to customary closing conditions including regulatory approvals, of MedAlliance. A press release notes that the agreement includes an...
MedAlliance SELUTION SLR

FDA grants IDE approval for Selution SLR drug-eluting balloon

MedAlliance’s Selution SLR drug-eluting balloon (DEB) has received investigational device exemption (IDE) approval from the US Food and Drug Administration, making it the first...

New sirolimus data provide encouragement despite “potentially disappointing” efficacy results

The results of a small-scale pilot study from Asia have indicated “potentially disappointing” results with a novel drug-eluting balloon in treating dysfunctional arteriovenous access...

Fistula trials among key areas set to benefit from MedAlliance acquiring...

Arteriovenous fistula (AVF) access is one of the key areas that is set to receive a boost following MedAlliance’s acquisition of its partner MDK...

ISABELLA trial for the treatment of failing AV fistulas in haemodialysis...

MedAlliance has announced completion of patient enrolment in the ISABELLA clinical trial with the Selution SLR 018 drug-eluting balloon (DEB) for the treatment of...